流行性冠状病毒感染与SARS-CoV-2 Fc受体结合抗体有关

David J Bean1, Yan Mei Liang2, Frida Avila2

  • 1Department of Virology, Immunology and Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA.

Journal of virology
|May 19, 2025
PubMed
概括

最近流行冠状病毒 (eCoV) 感染可能通过增强交叉反应性抗体来预防严重的COVID-19. 这些抗体增强了Fc受体的结合,潜在地改善了对SARS-CoV-2的免疫反应.